|
RBM19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.043600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.379800E-01 |
| Normal-vs-Stage2 |
3.403600E-01 |
| Normal-vs-Stage3 |
1.239150E-01 |
| Normal-vs-Stage4 |
9.081800E-01 |
| Stage1-vs-Stage2 |
5.830800E-01 |
| Stage1-vs-Stage3 |
1.788790E-01 |
| Stage1-vs-Stage4 |
5.361600E-01 |
| Stage2-vs-Stage3 |
6.701600E-01 |
| Stage2-vs-Stage4 |
3.602400E-01 |
| Stage3-vs-Stage4 |
1.806960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.186800E-01 |
| Normal-vs-AfricanAmerican |
9.010000E-01 |
| Normal-vs-Asian |
5.582200E-01 |
| Caucasian-vs-AfricanAmerican |
8.191200E-01 |
| Caucasian-vs-Asian |
1.562010E-01 |
| AfricanAmerican-vs-Asian |
5.037800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.930600E-01 |
| Normal-vs-Female |
3.940200E-01 |
| Male-vs-Female |
9.978600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.724800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.527000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.655600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.929910E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.479600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.925000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.801940E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.182000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.007800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.633420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.422400E-02 |
| Classical-VS-Follicular |
2.18079999999565E-05 |
| Classical-VS-Other |
2.203400E-01 |
| Classical-VS-Normal |
7.546800E-01 |
| Tall-VS-Follicular |
2.568600E-01 |
| Tall-VS-Other |
6.955800E-01 |
| Tall-VS-Normal |
1.160760E-01 |
| Follicular-VS-Other |
8.425400E-01 |
| Follicular-VS-Normal |
8.957800E-03 |
| Other-VS-Normal |
2.850400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.263620E-01 |
| Normal-vs-N1 |
7.119000E-01 |
| N0-vs-N1 |
1.293760E-01 |
|
|
